Singular Health Group (ASX:SHG) - Share price, News & Analysis

SHG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	3/6
Dividends	0/6

SHG Overview

Rewards

Revenue grew by 259% over the past year

Risk Analysis

Makes less than USD$1m in revenue (A$456K)

Less than 3 years of financial data is available

Does not have a meaningful market cap (A$21M)

Price History & Performance

Summary of all time highs, changes and price drops for Singular Health Group
Historical stock prices
Current Share Price	AU$0.21
52 Week High	AU$0.16
52 Week Low	AU$0.75
Beta	0
1 Month Change	-17.65%
3 Month Change	-26.32%
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-44.74%

Recent News & Updates

Sep 15

Singular Health Group (ASX:SHG) Is In A Good Position To Deliver On Growth Plans

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...

Shareholder Returns

	SHG	AU Healthcare Services	AU Market
7D	27.3%	1.4%	1.7%
1Y	n/a	38.8%	20.2%

Return vs Industry: Insufficient data to determine how SHG performed against the Australian Healthcare Services industry.

Return vs Market: Insufficient data to determine how SHG performed against the Australian Market.

Price Volatility

Is SHG's price volatile compared to industry and market?
SHG volatility
SHG Beta	0
Industry Beta	0.49
Market Beta	1

Stable Share Price: SHG is not significantly more volatile than the rest of Australian stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: SHG's weekly volatility (11%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2017	n/a	Thomas Hanly	https://singular.health

Singular Health Group Ltd, a medical technology company, develops and commercializes volumetric rendering platform (VRP) for the 3D and virtual reality (VR) visualization of anatomy using standard radiological imagery. It offers 3Dicom Viewer, a cross-platform application that allows its users to interact with standard 2D medical images; 3DicomVSP, an end-to-surgical planning platform; Health Academy, a scalable multi-lingual platform that provides templated curriculum aligned lessons; and GeoVR, a cloud platform for use in the mineral resources sector. The company was founded in 2017 and is headquartered in Subiaco, Australia.

Singular Health Group Fundamentals Summary

How do Singular Health Group's earnings and revenue compare to its market cap?
SHG fundamental statistics
Market Cap	AU$20.56m
Earnings (TTM)	-AU$4.46m
Revenue (TTM)	AU$456.34k

47.4x

P/S Ratio

-4.8x

P/E Ratio

Is SHG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report
SHG income statement (TTM)
Revenue	AU$456.34k
Cost of Revenue	AU$189.77k
Gross Profit	AU$266.58k
Expenses	AU$4.72m
Earnings	-AU$4.46m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)	-0.043
Gross Margin	58.41%
Net Profit Margin	-976.48%
Debt/Equity Ratio	0.03%

How did SHG perform over the long term?

See historical performance and comparison

Valuation

Is Singular Health Group undervalued compared to its fair value and its price relative to the market?

4.25x

Price to Book (PB) ratio

Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate SHG's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate SHG's fair value to establish if it is undervalued.

Price To Earnings Ratio

PE vs Industry: SHG is unprofitable, so we can't compare its PE Ratio to the Global Healthcare Services industry average.

PE vs Market: SHG is unprofitable, so we can't compare its PE Ratio to the Australian market.

Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SHG's PEG Ratio to determine if it is good value.

Price to Book Ratio

PB vs Industry: SHG is overvalued based on its PB Ratio (4.2x) compared to the AU Healthcare Services industry average (4.1x).

Future Growth

How is Singular Health Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

40.7%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Singular Health Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Past Performance

How has Singular Health Group performed over the past 5 years?

-424.8%

Last years earnings growth

Earnings and Revenue History

Quality Earnings: SHG is currently unprofitable.

Growing Profit Margin: SHG is currently unprofitable.

Past Earnings Growth Analysis

Earnings Trend: Unable to establish if SHG's year-on-year earnings growth rate was positive over the past 5 years as it has been trading publicly for less than 3 years.

Accelerating Growth: Unable to compare SHG's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SHG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (39.5%).

Return on Equity

High ROE: SHG has a negative Return on Equity (-87.68%), as it is currently unprofitable.

Financial Health

How is Singular Health Group's financial position?

Financial Position Analysis

Short Term Liabilities: SHG's short term assets (A$4.3M) exceed its short term liabilities (A$260.6K).

Long Term Liabilities: SHG's short term assets (A$4.3M) exceed its long term liabilities (A$84.5K).

Debt to Equity History and Analysis

Debt Level: SHG's debt to equity ratio (0.03%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if SHG's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: SHG's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if SHG's interest payments on its debt are well covered by EBIT.

Balance Sheet

Dividend

What is Singular Health Group current dividend yield, its reliability and sustainability?

Dividend Yield vs Market

Notable Dividend: Unable to evaluate SHG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SHG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SHG's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SHG's dividend payments have been increasing.

Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.

Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SHG's dividend in 3 years as they are not forecast to pay a notable one for the Australian market.

Next Steps

Explore strong dividend paying companies in the Healthcare industry.

Management

How experienced are the management team and are they aligned to shareholders interests?

1.2yrs

Average board tenure

CEO

Thomas Hanly

no data

Tenure

Mr. Thomas Hanly, B.A. is Managing Director and Chief Executive Officer at Singular Health Group Limited and serves its Director since February 20, 2020. He serves as Non-Executive Director of Mineral Fert...

Board Members

Experienced Board: SHG's board of directors are not considered experienced ( 1.2 years average tenure), which suggests a new board.

Ownership

Who are the major shareholders and have insiders been buying or selling?

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: SHG only recently listed within the past 12 months.

Data	Last Updated (UTC time)
Company Analysis	2021/10/20 07:05
End of Day Share Price	2021/10/20 00:00
Earnings	2021/06/30
Annual Earnings	2021/06/30

Market Cap

7D

1Y

Updated

Data